• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱法测定血浆、尿液和组织匀浆中的化学保护剂2-(烯丙硫基)吡嗪。

Determination of a chemoprotective agent, 2-(allylthio)pyrazine, in plasma, urine and tissue homogenates by high-performance liquid chromatography.

作者信息

Han K S, Woo S J, Koo C H, Lee M G

机构信息

College of Pharmacy, Seoul National University, South Korea.

出版信息

J Chromatogr B Biomed Sci Appl. 1998 Jun 12;710(1-2):239-42. doi: 10.1016/s0378-4347(98)00097-8.

DOI:10.1016/s0378-4347(98)00097-8
PMID:9686894
Abstract

A high-performance liquid chromatographic method was developed for the determination of a chemoprotective agent, 2-(allylthio)pyrazine (I), in human plasma and urine, and in rat blood and tissue homogenate using diazepam as an internal standard. The sample preparation was simple; 2.5 volumes of acetonitrile were added to the biological sample to deproteinize it. A 50-100 microl aliquot of the supernatant was injected onto a C18 reversed-phase column. The mobile phase employed was acetonitrile-water (55:45, v/v), and it was run at a flow-rate of 1.5 ml/min. The column effluent was monitored using an ultraviolet detector at 330 nm. The retention times for I and the internal standard were 4.0 and 5.1 min, respectively. The detection limits of I in human plasma and urine, and in rat tissue homogenate (including blood) were 20, 20 and 50 ng/ml, respectively. The coefficients of variation of the assay (within-day and between-day) were generally low (below 6.1%) in a concentration range from 0.02 to 10 microg/ml for human plasma and urine, and for rat tissue homogenate. No interferences from endogenous substances were found.

摘要

建立了一种高效液相色谱法,以地西泮为内标,用于测定人血浆、尿液以及大鼠血液和组织匀浆中的化学保护剂2-(烯丙硫基)吡嗪(I)。样品制备简单;向生物样品中加入2.5倍体积的乙腈使其脱蛋白。取50 - 100微升上清液注入C18反相柱。所用流动相为乙腈 - 水(55:45,v/v),流速为1.5毫升/分钟。使用紫外检测器在330纳米处监测柱流出物。I和内标的保留时间分别为4.0分钟和5.1分钟。I在人血浆、尿液以及大鼠组织匀浆(包括血液)中的检测限分别为20、20和50纳克/毫升。在人血浆、尿液以及大鼠组织匀浆浓度范围为0.02至10微克/毫升时,该测定法的变异系数(日内和日间)通常较低(低于6.1%)。未发现内源性物质的干扰。

相似文献

1
Determination of a chemoprotective agent, 2-(allylthio)pyrazine, in plasma, urine and tissue homogenates by high-performance liquid chromatography.采用高效液相色谱法测定血浆、尿液和组织匀浆中的化学保护剂2-(烯丙硫基)吡嗪。
J Chromatogr B Biomed Sci Appl. 1998 Jun 12;710(1-2):239-42. doi: 10.1016/s0378-4347(98)00097-8.
2
Determination of a chemopreventive agent, Oltipraz, in rat plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定大鼠血浆和尿液中的化学预防剂奥替普拉。
Res Commun Mol Pathol Pharmacol. 2001 Jul-Aug;110(1-2):133-8.
3
Determination of a new isoquinolinedione derivative, 7-anilino-5,8-isoquinolinedione, in plasma, urine and tissue homogenates by high-performance liquid chromatography.采用高效液相色谱法测定血浆、尿液和组织匀浆中的新型异喹啉二酮衍生物7-苯胺基-5,8-异喹啉二酮。
J Pharm Biomed Anal. 2002 Oct 15;30(3):519-26. doi: 10.1016/s0731-7085(02)00398-9.
4
Determination of a new naphthoquinone derivative, NQ12, in human plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定人血浆和尿液中一种新型萘醌衍生物NQ12的含量。
Res Commun Mol Pathol Pharmacol. 1999 Jan;103(1):101-7.
5
Determination of a new proton pump inhibitor, YH1885, in human plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定人血浆和尿液中新型质子泵抑制剂YH1885的含量。
J Chromatogr B Biomed Sci Appl. 1997 Aug 29;696(2):312-6. doi: 10.1016/s0378-4347(97)00238-7.
6
Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.采用高效液相色谱法测定血浆、尿液、血液和组织匀浆中新型抗溃疡药物YJA - 20379 - 1的含量。
Res Commun Mol Pathol Pharmacol. 1997 Jul;97(1):107-12.
7
Determination of a new asiatic acid derivative, AS 2-006A in rat plasma and urine, and human plasma by high-performance liquid chromatography.采用高效液相色谱法测定大鼠血浆、尿液及人体血浆中一种新的积雪草苷衍生物AS 2-006A。
Res Commun Mol Pathol Pharmacol. 1999;104(3):339-44.
8
Determination of a new antiulcer agent, eupatilin, in rat plasma, bile, urine, and liver homogenate by high-performance liquid chromatography.用高效液相色谱法测定大鼠血浆、胆汁、尿液和肝匀浆中一种新型抗溃疡药物灯盏乙素的含量。
Res Commun Mol Pathol Pharmacol. 1997 Aug;97(2):165-70.
9
Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定血浆和尿液中新型碳青霉烯衍生物DA-1131的含量。
J Chromatogr B Biomed Sci Appl. 1997 Jan 10;688(1):95-9. doi: 10.1016/s0378-4347(97)88060-7.
10
Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography.采用高效液相色谱法测定血浆和尿液中新型磷酸二酯酶V抑制剂DA-8159的含量。
J Pharm Biomed Anal. 2002 Oct 15;30(3):527-33. doi: 10.1016/s0731-7085(02)00397-7.